Analysts predict that Imperva Inc (NASDAQ:IMPV) will post $84.16 million in sales for the current fiscal quarter, according to Zacks. Eight analysts have made estimates for Imperva’s earnings, with estimates ranging from $83.50 million to $86.51 million. Imperva posted sales of $72.31 million in the same quarter last year, which suggests a positive year over year growth rate of 16.4%. The firm is expected to report its next quarterly earnings report after the market closes on Thursday, April 26th.
On average, analysts expect that Imperva will report full year sales of $372.18 million for the current financial year, with estimates ranging from $370.60 million to $375.45 million. For the next financial year, analysts anticipate that the business will report sales of $427.34 million per share, with estimates ranging from $422.00 million to $434.00 million. Zacks Investment Research’s sales calculations are an average based on a survey of analysts that cover Imperva.
Imperva (NASDAQ:IMPV) last posted its earnings results on Thursday, February 8th. The software maker reported $0.40 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.27 by $0.13. Imperva had a net margin of 7.11% and a negative return on equity of 3.28%. The firm had revenue of $91.10 million during the quarter, compared to analyst estimates of $91.11 million. During the same quarter in the prior year, the business posted $0.32 EPS. The business’s revenue was up 16.2% compared to the same quarter last year.
In other Imperva news, Director Anthony J. Bettencourt sold 66,037 shares of the company’s stock in a transaction dated Tuesday, February 20th. The shares were sold at an average price of $46.98, for a total transaction of $3,102,418.26. Following the sale, the director now directly owns 66,037 shares of the company’s stock, valued at $3,102,418.26. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CRO Michael D. Mooney sold 24,454 shares of the company’s stock in a transaction dated Tuesday, February 20th. The shares were sold at an average price of $47.18, for a total transaction of $1,153,739.72. Following the sale, the executive now directly owns 24,454 shares in the company, valued at $1,153,739.72. The disclosure for this sale can be found here. 1.10% of the stock is owned by corporate insiders.
Several institutional investors have recently made changes to their positions in the company. MetLife Investment Advisors LLC purchased a new stake in shares of Imperva in the fourth quarter worth about $625,000. Teachers Advisors LLC lifted its holdings in shares of Imperva by 2.3% in the fourth quarter. Teachers Advisors LLC now owns 61,251 shares of the software maker’s stock worth $2,432,000 after buying an additional 1,381 shares in the last quarter. HBK Investments L P purchased a new stake in shares of Imperva in the fourth quarter worth about $1,171,000. Two Sigma Investments LP lifted its holdings in shares of Imperva by 92.2% in the fourth quarter. Two Sigma Investments LP now owns 308,711 shares of the software maker’s stock worth $12,256,000 after buying an additional 148,077 shares in the last quarter. Finally, Two Sigma Advisers LP lifted its holdings in shares of Imperva by 11.8% in the fourth quarter. Two Sigma Advisers LP now owns 355,504 shares of the software maker’s stock worth $14,114,000 after buying an additional 37,400 shares in the last quarter.
NASDAQ IMPV opened at $47.30 on Tuesday. Imperva has a 1 year low of $37.17 and a 1 year high of $52.40. The firm has a market capitalization of $1,621.96, a PE ratio of -168.93, a PEG ratio of 53.26 and a beta of 1.67.
ILLEGAL ACTIVITY NOTICE: This news story was originally posted by Chaffey Breeze and is the property of of Chaffey Breeze. If you are viewing this news story on another publication, it was stolen and republished in violation of United States and international copyright laws. The correct version of this news story can be viewed at https://www.chaffeybreeze.com/2018/04/17/84-16-million-in-sales-expected-for-imperva-inc-impv-this-quarter.html.
Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Imperva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva and related companies with MarketBeat.com's FREE daily email newsletter.